AN4035

Recent news mentioning AN4035

• 2026-08-03 — Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia

Appears alongside

• HREC
• ADC

Browse the full archive →